CVS Health Corp CV agreed to purchase Signify Health Inc SGFY for $30.50 per share in cash for a total transaction value of approximately $8 billion.
Signify Health shares were up 0.2% on Tuesday at $28.83.
Several analysts changed their price targets on Signify Health today.
- Baird raised the stock’s price target to $30.5 from $28. Baird analyst Vikram Kesavabhotla downgraded the stock to neutral from outperform.
- RBC capital raised the price target on the stock to $30.5 from $20. RBC Capital analyst Sean Dodge endorsed Signify Health with a sector perform.
- JP Morgan, but lowered the target price on the stock to $30.5 from $32. JP Morgan analyst Anne Samuel downgraded the stock to neutral from overweight.
- Piper Sandler also lowered the price target on the stock to $30.5 from $34. Piper Sandler’s analyst Jessica Tassan downgraded the stock to neutral from overweight.
